How To Use CPT Code 90654

CPT 90654 describes the administration of a trivalent influenza vaccine intradermally. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90654?

CPT 90654 can be used to describe the administration of a trivalent influenza vaccine intradermally. This code is used when a healthcare provider administers the vaccine to protect the patient from three strains of the influenza virus.

2. Official Description

The official description of CPT code 90654 is: ‘Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use.’

3. Procedure

1. The healthcare provider presents the options for immunization to the parent, guardian, or patient.
2. The risks, benefits, and potential side effects of the vaccine are reviewed with the patient.
3. The patient is appropriately prepped, and the healthcare provider administers the trivalent influenza vaccine intradermally.
4. The vaccine protects the patient from infection by three strains of the influenza virus.

4. Qualifying circumstances

Patients eligible to receive CPT 90654 are those who require protection from three strains of the influenza virus. The vaccine is administered by a healthcare provider intradermally.

5. When to use CPT code 90654

CPT code 90654 should be used when a healthcare provider administers the trivalent influenza vaccine intradermally to protect the patient from three strains of the influenza virus.

6. Documentation requirements

To support a claim for CPT 90654, the healthcare provider must document the following information:

• The product administered (trivalent influenza vaccine)
• The administration route (intradermal)
• The purpose of the vaccine (protection from three strains of the influenza virus)

7. Billing guidelines

When billing for CPT 90654, ensure that the healthcare provider administers the vaccine intradermally. Follow the appropriate coding guidelines for reporting the vaccine administration, the actual vaccine, and any associated office visit. It is important to include sufficient documentation from the provider explaining the product administered, administration route, and purpose of the vaccine.

8. Historical information

CPT 90654 was added to the Current Procedural Terminology system on January 1, 2012. The code was previously described as ‘Influenza virus vaccine, split virus, preservative-free, for intradermal use.’ There have been no updates to the code since its addition.

9. Examples

1. A healthcare provider administers the trivalent influenza vaccine intradermally to a patient to protect them from three strains of the influenza virus.
2. A nurse administers the trivalent influenza vaccine intradermally to a child to provide immunity against three strains of the influenza virus.
3. A pharmacist administers the trivalent influenza vaccine intradermally to an elderly patient to protect them from three strains of the influenza virus.
4. A healthcare provider administers the trivalent influenza vaccine intradermally to a pregnant woman to provide immunity against three strains of the influenza virus.
5. A physician administers the trivalent influenza vaccine intradermally to a patient with a compromised immune system to protect them from three strains of the influenza virus.
6. A nurse practitioner administers the trivalent influenza vaccine intradermally to a healthcare worker to provide immunity against three strains of the influenza virus.
7. A healthcare provider administers the trivalent influenza vaccine intradermally to a patient with a chronic respiratory condition to protect them from three strains of the influenza virus.
8. A pharmacist administers the trivalent influenza vaccine intradermally to a patient with a heart condition to provide immunity against three strains of the influenza virus.
9. A nurse administers the trivalent influenza vaccine intradermally to a patient with diabetes to protect them from three strains of the influenza virus.
10. A healthcare provider administers the trivalent influenza vaccine intradermally to a patient with a weakened immune system to provide immunity against three strains of the influenza virus.